JP2006516588A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006516588A5 JP2006516588A5 JP2006501711A JP2006501711A JP2006516588A5 JP 2006516588 A5 JP2006516588 A5 JP 2006516588A5 JP 2006501711 A JP2006501711 A JP 2006501711A JP 2006501711 A JP2006501711 A JP 2006501711A JP 2006516588 A5 JP2006516588 A5 JP 2006516588A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- formula
- defined above
- compound according
- ylmethanesulfonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 16
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000012261 overproduction Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000006239 protecting group Chemical group 0.000 claims 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 125000001072 heteroaryl group Chemical group 0.000 claims 1
- 125000000623 heterocyclic group Chemical group 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 125000002572 propoxy group Chemical group [*]OC([H])([H])C(C([H])([H])[H])([H])[H] 0.000 claims 1
- -1 quinolin-3-ylmethanesulfonyl Chemical group 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0302431.2A GB0302431D0 (en) | 2003-01-30 | 2003-01-30 | Novel compounds |
| PCT/EP2004/000954 WO2004067502A1 (en) | 2003-01-30 | 2004-01-30 | Sulphonyl hydroxamic acid derivatives as inhibitors of s-cd23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006516588A JP2006516588A (ja) | 2006-07-06 |
| JP2006516588A5 true JP2006516588A5 (enExample) | 2007-02-22 |
Family
ID=9952325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006501711A Pending JP2006516588A (ja) | 2003-01-30 | 2004-01-30 | Ｓ−ｃｄ２３のインヒビターとしてのスルホニルヒドロキサム酸誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20060247271A1 (enExample) |
| EP (1) | EP1599444A1 (enExample) |
| JP (1) | JP2006516588A (enExample) |
| GB (1) | GB0302431D0 (enExample) |
| WO (1) | WO2004067502A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010032147A2 (en) * | 2008-09-19 | 2010-03-25 | Pfizer Inc. | Hydroxamic acid derivatives useful as antibacterial agents |
| US8664401B2 (en) | 2009-12-16 | 2014-03-04 | Pfizer Inc. | N-linked hydroxamic acid derivatives useful as antibacterial agents |
| EA024782B1 (ru) | 2011-03-07 | 2016-10-31 | Пфайзер Инк. | Производные фторпиридинона, полезные в качестве антибактериальных агентов |
| MX2013011526A (es) | 2011-04-08 | 2013-12-06 | Pfizer | Derivados de isoxazol utiles como agentes antibacteriales . |
| CA2830866A1 (en) | 2011-04-08 | 2012-10-11 | Pfizer Inc. | Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030199571A1 (en) * | 1999-12-24 | 2003-10-23 | Gordon Bruton | (Hetero) Bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives |
| EP1289980B1 (en) * | 2000-05-25 | 2004-11-17 | Smithkline Beecham Plc | Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides |
| US20030187023A1 (en) * | 2000-07-17 | 2003-10-02 | Keiji Kubo | Sulfone derivatives, process for their production and use thereof |
-
2003
- 2003-01-30 GB GBGB0302431.2A patent/GB0302431D0/en not_active Ceased
-
2004
- 2004-01-30 US US10/543,974 patent/US20060247271A1/en not_active Abandoned
- 2004-01-30 WO PCT/EP2004/000954 patent/WO2004067502A1/en not_active Ceased
- 2004-01-30 JP JP2006501711A patent/JP2006516588A/ja active Pending
- 2004-01-30 EP EP04706684A patent/EP1599444A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005053931A5 (enExample) | ||
| JP2006526031A5 (enExample) | ||
| JP2008511601A5 (enExample) | ||
| JP2006514626A5 (enExample) | ||
| JP2005523922A5 (enExample) | ||
| JP2006509749A5 (enExample) | ||
| JP2012510502A5 (enExample) | ||
| JP2014500861A5 (enExample) | ||
| JP2007520440A5 (enExample) | ||
| JP2006505543A5 (enExample) | ||
| JP2007246474A5 (enExample) | ||
| JP2005526836A5 (enExample) | ||
| EP2412707A3 (en) | 3-[2-(3-Amino-2-oxo-2H-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors | |
| EP2308828A3 (en) | CaSR antagonist | |
| JP2015508092A5 (enExample) | ||
| JP2004528385A5 (enExample) | ||
| JP2007514691A5 (enExample) | ||
| JP2010534246A5 (enExample) | ||
| JP2007538031A5 (enExample) | ||
| JP2012511558A5 (enExample) | ||
| JP2005517008A5 (enExample) | ||
| JP2005510457A5 (enExample) | ||
| JP2004525178A5 (enExample) | ||
| JP2005516898A5 (enExample) | ||
| JP2010535751A5 (enExample) |